A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
Clinical trial NCT05920876 · UNKNOWN
Trial details
- NCT number
- NCT05920876
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2024-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.